The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Pathway-based signature analysis of RNA-seq data to reveal new targetable avenues for metastatic castration-resistant prostate cancer (mCRPC) patients (pts): Preliminary results from the SU2C/PCF/AACR West Coast Prostate Cancer Dream Team (WCDT).
Adrian Bivol
No relevant relationships to disclose
Robert Baertsch
No relevant relationships to disclose
Artem Sokolov
No relevant relationships to disclose
Evan Paull
No relevant relationships to disclose
Yulia Newton
No relevant relationships to disclose
Theodore C. Goldstein
No relevant relationships to disclose
Adam Foye
No relevant relationships to disclose
Nader Pourmand
No relevant relationships to disclose
Jack Youngren
No relevant relationships to disclose
Rahul Parulkar
No relevant relationships to disclose
Asis Lopez
No relevant relationships to disclose
Ralph de Vere White
No relevant relationships to disclose
Joshi J. Alumkal
No relevant relationships to disclose
Alexandria Toschi
No relevant relationships to disclose
Tomasz M. Beer
Consultant or Advisory Role - Janssen Japan
Research Funding - Astellas Pharma; Janssen; Medivation
Christopher P. Evans
Consultant or Advisory Role - Janssen-Ortho; Medivation/Astellas
Honoraria - Janssen-Ortho
Research Funding - Medivation/Astellas
Martin Edwin Gleave
No relevant relationships to disclose
Owen Witte
No relevant relationships to disclose
Eric Jay Small
No relevant relationships to disclose
Joshua M. Stuart
Consultant or Advisory Role - Five3 Genomics
Stock Ownership - Five3 Genomics